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SOMMARIO 
Negli organismi sani l’infiammazione è il primo meccanismo di difesa 
contro i microorganismi patogeni. I monociti e i macrofagi hanno un 
ruolo chiave in questo processo e una alterazione della loro attività è 
alla base di molte condizioni patologiche. Per questi motivi, capire i 
meccanismi molecolari dell’attivazione monocito-macrofagica è il 
primo passo per lo studio delle malattie infiammatorie ed 
eventualmente, per lo sviluppo di strategie terapeutiche. Nonostante 
ciò non sono ancora del tutto chiari i meccanismi di attivazione 
funzionale dei monociti e la loro caratterizzazione fenotipica durante 
la polarizzazione M1/M2. In questa tesi viene descritta la costruzione 
in vitro di un modello umano della reazione infiammatoria e lo 
sviluppo di un metodo bioinformatico mirato alla ricostruzione delle 
reti di regolazione genica alla base di questo processo. In 
particolare, monociti umani primari, isolati dal sangue di soggetti 
sani, sono stati messi in coltura ed esposti ad una serie di stimoli 
microambientali (chemiochine, citochine, temperatura, molecole di 
derivazione batterica, ecc.) propri dell’infiammazione fisiologica e i 
loro profili di espressione genica sono stati monitorati per 48 h 
tramite analisi con la tecnologia dei microarray. L’analisi 
computazionale inizia con l’identificazione dei geni differenzialmente 
espressi durante l’arco temporale e che, attraverso analisi di 
arricchimento, sembrano essere coinvolti nel processo 
infiammatorio. Questi geni possono essere considerati i regolatori del 
processo infiammatorio e per questo sono stati utilizzati come geni 
chiave per l’identificazione dei moduli di regolazione genica. Grazie a 
questo approccio bioinformatico è stato possibile identificare i geni 
caratterizzanti le differenti fasi della risposta infiammatoria ed è stato 
possibile ricostruire i loro moduli di connessione. Infine, è stata fatta 
una comparazione tra i risultati ottenuti dall’analisi computazionale 
del modello e dati pubblici ottenuti con la tecnica di 
immunoprecipitazione della cromatina associata al sequenziamento 
(ChIP-seq). 
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ABSTRACT 
In healthy organisms, inflammation is the first defense mechanism 
and monocytes and macrophages are among the key players of this 
process. Since a alteration of the activity of these cell populations is 
at the base of several pathological conditions, elucidating the 
molecular mechanisms of monocyte/macrophage activation 
represents a major step to study inflammatory disorders and, 
eventually, develop new therapeutic strategies. However, these 
mechanisms and their interplay during monocyte/macrophage 
activation still remain poorly characterized. Here, we report the setup 
of a physiological inflammation model, based on human primary 
cells, and of a bioinformatics approach that allow studying the 
development of the inflammatory reaction during its entire course 
and elucidating networks of molecular interactions which are at the 
basis of this process. Specifically, human blood monocytes isolated 
from blood of normal healthy donors have been cultured and 
exposed to a combination of factors reproducing physiological 
inflammatory conditions and their gene expression profiles monitored 
during a time course of 48 hours. The computational process starts 
with the identification of those genes whose expression changes 
during the time course and that, through enrichment analysis, appear 
to be involved in inflammatory processes. These genes can be 
considered as controllers of the process and thus are further used as 
regulators to identify regulatory modules. Using these computational 
methods we have been able to obtain genes that characterize the 
various steps of the inflammatory process and to reconstruct their 
connection modules. Finally, to validate our results we performed a 
comparison between data from the physiological inflammation model 
and data obtained from ChIP-seq that combines chromatin	  
immunoprecipitation with massively parallel DNA	  sequencing	  to	  identify	  
the	  binding	  sites of DNA-associated proteins 
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INTRODUCTION 
1.1 Omics data and their analysis  
The word that changed the science’s lexis and that gave the 
origins to a new era, was coined in a McDonald’s Raw Bar by 
Dr. Thomas H. Roderick, a geneticist at the Jackson 
Laboratory, Bar Harbor, ME, in 1986. He was looking with 
some colleagues for the name of a new journal, and he was 
looking for a word that would encompass sequencing, 
mapping, and new technologies, a word that could describe 
the genome as a functioning whole beyond just single genes 
or sequences spread around a chromosome (Kuska B., 1998). 
He came up with the word “genomics”.  From that moment on, 
begins the “omics” era and a large amount of words with 
suffix –omics spread out, every time to describe a big field in 
life sciences that focuses on large-scale data/information to 
understand life summarized in “omics” such as proteomics, 
genomics, metabolomics, and transcriptomics. In the case of 
transcriptomics the word encompass the study of the set of 
all RNA molecules, their structures and functions. Unlike the 
genome, the transcriptome can change with external 
conditions and stimuli, because it includes all mRNA 
transcripts and reflects the genes that are actively expressed 
in a given cell at a given moment under a particular condition. 
The study of transcriptomics, also referred to as expression 
profiling, is the study of the expression level of mRNAs through 
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high-throughput techniques like microarrays. The basic 
principle of microarray technology is complementary 
hybridization of nucleotides, as explained by the Watson–Crick 
double helical model of DNA. The mRNA from a given cell line 
or tissue is used to generate a labeled sample, sometimes 
termed the target, which is hybridized in parallel to a large 
number of DNA sequences, immobilized on a solid surface in 
an ordered topology. Although academic groups and 
commercial suppliers have developed many different 
microarray systems, in the most commonly used technology 
the arrayed material, generally termed the probe (being the 
equivalent to the probe used in a northern blot analysis), is an 
oligonucleotide sequence. In oligonucleotide arrays, short 20–
25mers are synthesized in situ, either by photolithography onto 
silicon wafers (high-density-oligonucleotide arrays from 
Affymetrix) or by ink-jet technology (developed by Rosetta 
Inpharmatics and licensed to Agilent Technologies). 
Microarrays allow the simultaneous measurement of tens of 
thousands of messenger RNA (mRNA) transcripts, this is why 
they are so powerful and why the use of high-throughput 
techniques has become routine in genome-wide studies. 
Public databases of microarray gene expression data have 
been quickly growing as the use of high-throughput techniques 
has become very common. Major repositories of microarray 
data, as Gene Expression Omnibus (Edgar et al.,2002) and 
ArrayExpress (Brazma et al.,2003), are exceptionally rich 
mines of genomic information about the immune cells and 
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exploiting their content represents an unprecedented 
opportunity to improve the interpretation and validation of 
expression studies.  
Meta-analysis of large microarray expression datasets allows 
researchers to confirm biological hypotheses, formulated from 
results of a study, in a relatively inexpensive way, i.e. using 
data independently obtained in another laboratory, without the 
need of novel experiments. Meta-analysis also offers the 
opportunity of re-analyzing formerly available data, in 
combination with new samples and new computational 
methods, thus increasing the reliability and robustness of 
results. However, performing a meta-analysis of independent 
microarray studies requires to carefully handle the 
heterogeneity of array designs, which complicates cross-
platform integration. Moreover, although the power of 
microarrays and their capability in studying gene expression 
profile in many physiological or pathological conditions has 
been largely demonstrated, it’s very difficult to extrapolate the 
entire amount of data they contain and to interpret it to the 
best.  
The interpretation of the immunological data is complicated by 
the complexity of the immune system itself: several different 
cell types activated by several different stimuli and under 
several different conditions cooperate to make sure that 
pathogens are recognized and neutralized, and that infected 
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cells are killed. New molecules and new molecular 
mechanisms involved in pathogen recognition and immune 
response are still being discovered. For this reason, when 
evaluating an immune response, one should consider taking 
an approach for its characterization that elevates the study of 
the single components of the system (e.g., genes, proteins) to 
higher hierarchies, as entire genomic regions, groups of co-
expressed genes, functional modules, and networks of 
interactions. Since the networks of signals and relations 
among genes and regulators (e.g., transcription factors (TFs)) 
control the development of physio-pathological states, 
understanding how elementary biological objects act together 
and interact is fundamental for the advancement of biological 
knowledge.  
In this context, the goal is to analyze the correlation between 
genes, between their products, and the mechanisms of 
interaction that determine the physiological state of a cell or of 
a tissue and to recapitulate regulatory interactions of biological 
systems into mathematical models. However, the inference of 
gene regulatory networks is a challenging task because of 
incomplete knowledge of the involved molecules, the 
combinatorial nature of the problem and the fact that, often, 
available data are limited and inaccurate. Moreover, the 
presence of several feedback loops among these regulatory 
processes makes their organization and functioning very 
complex and this level of complexity cannot be addressed 
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using standard computational methods. Currently there are 
some methods to infer gene interactions using microarray 
expression profiles, as for example: i) Ingenuity Pathway 
Analysis (IPA; www.ingenuity.com) that allows to identify the 
most relevant signaling and metabolic pathways, molecular 
networks, and biological functions from a list of genes ii) 
Graphite web (Sales et al., 2013; 
www.graphiteweb.bio.unipd.it) that is a public web server for 
the analysis and visualization of biological pathways using 
high-throughput gene expression data, iii) Context Likelihood 
Relatedness (CLR; Faith et al., 2007) that infers regulatory 
interactions between transcription factors and their targets 
using a compendium of gene expression profiles and iv) The 
Algorithm for the Reconstruction of Accurate Cellular Networks 
(ARACNE; Margolin et al., 2006) that is based on a mutual 
information approach and it allows to reconstruct regulatory 
networks in mammalian cells. However, none of these allows 
identifying networks and modules of gene interaction using an 
integrated approach, which takes advantage of information 
from differentially expressed genes and functional 
enrichments. Therefore, standard methodologies for the 
analysis of gene expression profiles, which aim at identifying 
relevant genes from the statistical analysis of microarray 
signals, seem to be severely limited in unveiling the 
mechanisms governing the transcriptional cascade. 
 
6 	  
1.2 Monocytes, macrophages and dendritic cells 
Monocytes are produced by the bone marrow from 
hematopoietic stem cell precursors called monoblasts. 
Monoblasts are characterized by the expression of surface 
marker CD34. Monocytes circulate in the bloodstream for 
about one to three days and then move into tissues where they 
can differentiate into macrophages in order to replenish the 
pool of tissue macrophages following homeostatic loss, or to 
become inflammatory macrophages upon tissue damage. 
Monocytes have been considered as the systemic reservoir of 
myeloid precursors for the renewal of tissue macrophages and 
antigen-presenting Dendritic Cells (DC) (Figure 1.1). 
Macrophages are specialized phagocytic cells that attack and 
destroy foreign substances, cellular debris, infectious microbes 
and cancer cells; they also stimulate lymphocytes and other 
immune cells to respond to pathogens. Each type of 
macrophage, depending on where it reside, has a specific 
name: macrophages in connective tissue are often called 
histiocytes, macrophages in the skin and in the liver are 
respectively known as Langerhans and Kupffers cells, 
osteoclasts are macrophages in the bone and macrophages in 
the brain are microglial cells (Castagna et al., 2012). 
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Figure 1.1: Genealogy and nomenclature of monocyte, macrophages 
and dendritic cells.  
 
The differentiation of monocytes into macrophages is 
regulated by several cytokines, like interleukins and 
interferons. Depending on the stimuli that drive the 
differentiation, macrophage can be divided in distinct 
subpopulations, and they are being referred to generally as 
polarized macrophages. In particular two main macrophage 
phenotypes have been proposed: the inflammatory (M1) and 
the repair or anti-inflammatory phenotype (M2). The classically 
activated macrophages (M1) develop in response to 
inflammatory factors like the Th1 cytokine IFN-γ, LPS and 
TNF-α, and mediate resistance against intracellular parasites 
and tumors (Sica et al., 2012). Alternative M2 macrophages 
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are activated by Th2 cytokines, or FcγR binding in the 
presence of TLR agonist, or glucocorticoids and anti-
inflammatory molecules (M2a, M2b, M2c respectively), and 
they take part in parasite clearance, dampening of 
inflammation, tissue remodelling, and tumor promotion 
(Matzinger et al.,2007). Several in vitro and in vivo studies 
suggest that polarised M1 and M2 macrophages can switch 
from a phenotype to the other. A controversial issue is whether 
M1 and M2 macrophages consist of phenotypically distinct 
subpopulations that can serve different functions, or the same 
cells can shift from one to another functional phenotype based 
on microenviromental signals. While in several pathological 
conditions the latter seems to be the case (obesity-induced 
insulin resistance, type-2 diabetes, atherosclerotic lesions, 
cancer, endotoxin tolerance) (Figure 1.2), if M1 and M2 
macrophages can undergo dynamic transitions between 
different functional states during a “physiological” inflammatory 
response is still unknown.  
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Figure 1.2: Schematic representation of macrophage plasticity and 
polarization in pathology (Sica et al., 2012) 
Monocytes can differentiate also into dendritic cells and can be 
found as immature DCs in the blood. Dendritic cells are a 
critical link in the immune system. Their role is to monitor the 
body seeking out and capturing foreign invaders, called 
antigens (whether these are bacteria, viruses, or dangerous 
toxins), afterwards dendritic cells convert them into smaller 
pieces and display the antigenic fragments on their cell 
surfaces. Then DCs move to lymph nodes or to the spleen 
where they activate other cells of the immune system against 
the invaders, in particular B cells and killer T cells that, 
respectively, make antibodies to neutralize the invaders and 
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activate specific attacks to destroy them (Clark, 1997). There 
are two major types of DCs in human blood and these are 
myeloid DC (mDC) CD11c+ BDCA1+ and plasmacytoid DC 
(pDC) CD11c− BDCA2+ (CD303+). The two subsets differ in 
the expression of highly conserved microbial pattern 
recognition receptors, known as Toll-like receptors (TLR), but 
both are able to induce the stimulation of naive T cells. The 
dendritic cells also participate in the mechanism known as 
tolerance that restrains the T cells activity. If dendritic cells are 
too tolerant, this can create a permissive environment for 
chronic infectious agents or for tumors. If DCs are not enough 
tolerant, the immune system can lead to autoimmune diseases 
(rheumatoid arthritis and multiple sclerosis) (Ganguly et al., 
2013). Chronic inflammatory diseases and autoimmune 
disorders are characterized by persistent inflammation and 
immune activation. This chronic activation is probably triggered 
by exogenous stimuli (infection or mechanical stress) which 
facilitate the wrong recognition of self-antigens. In 
physiological conditions the inflammatory reaction is generally 
stimulated at the tissue level as a response to an event of 
danger (for example, a bacterial infection). After the contact 
with the microorganism, tissue produces factors such as 
chemokines that attract monocytes to the site of inflammation. 
In the tissue, activated monocytes begin the inflammation 
reaction that, usually, is followed by the destruction and the 
phagocytosis of the microorganism. This kind of inflammatory 
reaction is considered as a mechanism of innate immunity 
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which is quicker than the mechanism of adaptive immunity. 
When the injurious stimulus is cleared, tissue produces anti-
inflammatory cytokines. This kind of cytokines can induce the 
switch of macrophages polarization from a pro-inflammatory 
phenotype to an anti-inflammatory phenotype. In fact, in this 
stage macrophages begin to produce growth factors, tissue 
factors and anti-inflammatory cytokines, including TGF-β, 
responsible for the reconstruction and tissue remodeling. 
There is no information at present on the features of the entire 
course of the inflammatory reaction and on the possibility that 
the same cell population could be first polarized towards an 
effector inflammatory program and subsequently re-polarized 
to the deactivation program. 
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1.3 Aim of the study  
The research activity presented in this thesis wants to 
contribute to filling the gaps in the bioinformatics analysis of 
microarray data of immune cells.  
Specifically, we focused on  
i) the development and the 
application of computational 
strategies for the meta-analysis of 
gene expression data of the 
immune system cells, obtained 
from public repositories. 
ii) the development of a 
bioinformatics approach that allow 
studying the inflammatory reaction 
during its entire course  
iii) the development of a 
bioinformatics pipeline to 
reconstruct gene regulatory 
networks and decipher 
transcriptional modules in this 
process. 
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MATERIALS AND METHODS 
This chapter contains a description of gene expression and 
ChIP-seq data used in this thesis. Each dataset is fully 
reviewed and detailed. Following paragraphs describe:  i) how 
different datasets were combined to construct and analyze a 
proprietary meta-database of gene expression profiles of 
monocytes macrophages and dendritic cells; ii) the tools used 
to set up a pipeline to analyze an in vitro model of 
physiological inflammation. Finally, the methods used for 
ChIP-seq analysis are briefly presented. 
2.1 Model of physiological inflammation 
We developed an in vitro model of physiological inflammation, 
based on human primary cells, that could allow us to study the 
development of the inflammatory reaction during its entire 
course, thus opening the possibility of accurately 
characterizing the development and regulation of human 
macrophage functions. The in vitro model of physiological 
inflammation consists in a 48-hour culture of primary human 
monocytes isolated from 9 healthy donors. During the culture, 
monocytes are exposed sequentially to a series of stimuli 
(Figure 2.1) that mimic conditions in a simplified 
microenvironment that develops in inflamed tissue (Italiani et 
al., 2011). In particular, cells were cultured at the following 
experimental conditions:  
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− time 0: beginning of the culture at 37° C and addition of 
CCL2;  
− time +2 hours: removal of CCL2, addition of LPS and 
increasing temperature to 39° C;  
− time +3 hours: addition of TNF;  
− time +7 hours: addition of IFNγ;  
− time +14 hours: removal of inflammatory stimuli, and 
addition of IL10. Lowering the temperature to 37° C;  
− time +24 hours: IL10 removal, addition of TGFβ, and 
maintenance of temperature at 37° C.  
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Figure 2.1: Graphic representation of the in vitro model of 
inflammation based on human primary monocytes. Freshly isolated 
monocytes are first exposed to the chemokine CCL2 for 2 h at 37°C. 
At 2 h, monocytes are exposed to LPS and the temperature is raised 
to 39°C. Temperature is then kept at 39°C until 14 h while TNF-α and 
IFN-γ are added at 3 and 7 hours, respectively. At 14 h all the 
inflammatory stimuli are washed off, the temperature brought down 
to 37°C and fresh medium containing IL-10 added. Finally, 
monocytes are exposed to TGF-β at 24 hours. 
 
Total RNA was extracted from monocytes of 12 individual 
donors (3 for the “early” series: 0, 2.0-3.5 h; and 9 for the “late” 
series: 0, 4-48 h), using Qiagen miRNeasy kit (Qiagen), 
quantified spectrophotometrically (ND-1000, NanoDrop 
Technologies, Wilmington, DE), and checked for integrity by 
microcapillary electrophoresis (Agilent 2100 Bioanalyzer; 
Agilent Technologies, Palo Alto, CA). Samples were prepared 
starting from 0.1-1 µg total RNA, using the GeneChip®3’ IVT 
Express kit or the GeneChip® One Cycle cDNA Synthesis kit 
(Affymetrix, Santa Clara, CA), with identical results. 
Biotinylated cRNAs (15 µg) were fragmented and hybridized 
for 16 h at 45°C onto GeneChip® HG-U133 Plus 2.0 Arrays 
(Affymetrix). After washing and staining, arrays were scanned 
with the GeneChip® Scanner 3000 7G (Affymetrix) and 
fluorescent images were acquired and analyzed using GCOS 
software (Affymetrix) to generate a total of 60 raw intensity 
files (CEL files). The Affymetrix microarray HG-U133 Plus 2.0. 
allows simultaneous monitoring of 47,401 genes and human 
transcripts for a total of 54,675 probe set. 
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2.2 Genomic data 
The large amount of genomic data produced using microarray 
technology and DNA sequencing induced the creation of public 
repositories where storing and making publicly available to the 
scientific community this huge amount of data. Genomic data 
obtained during experiments designed to study a particular 
biological pathway, contains indeed a wealth of information not 
necessarily used in the original study and therefore available 
to other researchers for validating and confirming biological 
hypotheses. The larger repository of gene expression data is 
Gene Expression Omnibus (GEO; www.ncbi.nlm.nih.gov/geo/) 
at the National Center for Biotechnology Information (NCBI, 
Bethesda, MD, USA). Actually, the database contains 
1.031.592 samples divided into 42.965 experiments and 
obtained using 12.258 different platforms. We have exploited 
this very useful resource to validate the results obtained 
through the analysis of the model. Gene expression data 
stored in this database are organized into three categories: 
§ GSE that indicates the code of the series; 
§ GSM that indicates the code of the sample; 
§ GPL that indicates the code of the platform. 
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2.2.1 Meta-database of gene expression profiles of 
monocytes macrophages and dendritic cells. 
Datasets of human primary monocytes, macrophages, and 
dendritic cells (DC) were retrieved from Gene Expression 
Omnibus. Twenty-four series comprising 474 samples were 
downloaded from GEO of which 303 samples were used and 
organised in a proprietary database using the software A-
MADMAN (Bisognin et al 2009; table 2.1).  
 
GEO series Platform Total samples in series 
Samples 
used in our 
study 
Reference 
GSE4984  HG-U133 Plus2.0 12 6 Fulcher et al., 2006 
GSE5099 HG-U133A 30 14 Martinez et al., 2006 
GSE5547  HG-U133 Plus2.0 24 6 Humphrey et al., 2007 
GSE6965  HG-U133 Plus2.0 4 4 Mezger et al., 2008 
GSE7509  HG-U133 Plus2.0 26 26 Dhodapkar et al., 2007 
GSE7568  HG-U133 Plus2.0 25 25 Gratchev et al., 2008 
GSE7807  HG-U133 Plus2.0 8 4 Woszczek et al., 2008 
GSE8286  HG-U133A 9 9 Liu et al., 2008 
GSE8515  HG-U133A 15 15 Jura et al., 2008 
GSE8608  HG-U133 Plus2.0 6 1 Hofer et al., 2008 
GSE8658  HG-U133 Plus2.0 63 30 Szatmari et al., 2007 
GSE9080  HG-U133Av2 6 3 --- 
GSE9874  HG-U133A 60 11 Hägg et al., 2008 
GSE9946  HG-U133A 12 12 Popov et al., 2008 
GSE9988  HG-U133 Plus2.0 62 58 Dower et al., 2008 
GSE10856  HG-U133 Plus2.0 4 4 Chang et al., 2008 
GSE11393  HG-U133Av2 9 3 Llaverias et al., 2008 
GSE11430  HG-U133 Plus2.0 10 10 Maouche et al., 2008 
GSE11864  HG-U133 Plus2.0 10 10 Hu et al., 2008 
GSE12108  HG-U133 Plus2.0 14 13 Butchar et al., 2008 
GSE12773  HG-U133 Plus2.0 10 5 Rate et al., 2009 
GSE12837  HG-U133A 24 3 Coppe et al., 2009 
GSE13762  HG-U133 Plus2.0 15 15 Széles et al., 2009 
GSE14419  HG-U133Av2 16 16 --- 
 
Table 2.1: Complete list of the datasets used in this study and their 
sources. Genome-wide expression levels and meta-information of 
303 samples were organized in a proprietary meta-database using A-
MADMAN. 
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A-MADMAN is an open source web application which allows 
the automatic import of metadata from GEO records into a 
local relational database, the subsequent manual annotation 
and selection of samples through user-defined tags, and the 
selection of samples to be analyzed using a complex logical 
query on tags (Figure 2.2).   
 
 
Figure 2.2: A-MADMAN architecture. A-MADMAN includes console, 
job server and web-application. The console allows data retrieval, 
import and database filling. The web application is the user friendly 
and collaborative core of the system allowing data inspection, 
	  	   19	  
annotation and analysis. A Project is a collection of samples, series, 
tags, baskets and analyses owned by a user or by a group of 
users. Series and samples data and metadata come from GEO. The 
user can create an annotation system based on tags and assign 
samples to individuals. Queries on Boolean combinations of 
annotation tags are used to select and extract groups of samples, 
giving rise to baskets. 
 
All samples have been manually re-annotated and tagged 
based on the meta-information provided by GEO and by the 
original publications. In particular, we labeled 62 samples as 
untreated monocytes and 46 and 20 samples as M1 and M2 
activated monocytes/macrophages, respectively. Gene 
expression profiles have been generated from raw .CEL files 
using an ad-hoc procedure called Virtual-Chip (Bisognin et al., 
2010; Fallarino et al., 2010) and described in paragraph 2.3.2. 
The expression matrix has been analyzed to validate the 
results obtained from the analysis of our inflammation model.  
2.2.2 GSE16723 
This series contains chromatin immunoprecipitation 
sequencing (ChIP-seq) data from 10 samples of mouse 
primary bone marrow-derived macrophages unstimulated or 
treated with LPS (Barish et al., 2010). The experiment was 
performed using different antibodies but we focused on sample 
GSM611116 in which ChIP was carried out with an antibody 
specific for p65 (a subunit that forms the NF-κB complex). 
Specifically, bone marrow was purified and differentiated in 
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DMEM containing 20% fetal bovine serum, 30% L929 
conditioned media, and antibiotics for 5 days, then re-plated in 
macrophage serum free media (Invitrogen) overnight. The 
sample was treated with LPS for 3 h. Cells were fixed with 2 
mM disuccinimidyl glutarate for 30 minutes, then with 1% 
formaldehyde for 10 minutes, then glycine-quenched and 
harvested. Following fixation, nuclei were isolated, lysed in 
buffer containing 1% SDS, 10 mM EDTA, 50 mM Tris-HCl pH 
8.0, and protease inhibitors, and sheared with a Diagenode 
Bioruptor to chromatin fragment sizes of 200 – 1000 base 
pairs.  Chromatin was immunoprecipitated with antibody to 
p65. Short DNA reads were aligned against the mouse mm9 
reference genome using the Illumina Pipeline Suite v1.4. Peak 
detection was performed with the HOMER software suite 
(http://biowhat.ucsd.edu/homer/). IgG antibody was used as a 
negative control.  
2.2.3 GSE32324 
This series contains chromatin immunoprecipitation 
sequencing (ChIP-seq) data from THP1 cells (Iglesias MJ et 
al., 2012), a human monocytic cell line. We used samples 
GSM869213 and GSM869215 for our analysis. THP-1 cells 
were maintained in culture in RPMI 1640 medium containing 
10% fetal bovine serum, 1mM sodium pyruvate, 100 units/ml 
penicillin and 100 µg/ml streptomycin at 37°C with 5% CO2. 
For differentiation of THP-1 cells into macrophages a protocol 
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using conditioned media was used. To confirm differentiation 
of THP-1 monocytes into macrophages CD11b expression 
was measured using FACS and quantitative polymerase chain 
reaction (qPCR). THP-1 macrophages were stimulated with 
1ug/ml LPS (LPS-stimulated) from Escherichia coli for 2 hours 
to induce an acute inflammatory response. To confirm an 
induction of the inflammatory response in the THP-1 
macrophages, TNF mRNA levels were measured in control 
and LPS-stimulated samples. Immunoprecipitation was 
performed with specific antibodies raised against Sp1 
transcription factor. DNA-protein complexes were eluted, 
treated with RNase for 4–6 hours at 45°C and Proteinase K 
overnight at 65°C. DNA was extracted by 
phenol/chloroform/isoamyl alcohol extraction, purified and 
resuspended in water. Sequencing was performed on the 
Illumina Genome Analyzer I (SNP&SEQ technology platform, 
Uppsala University, Sweden).  Sequence reads were 35 bases 
or longer but truncated to 35 bases to ensure base quality over 
the entire read. Reads were aligned to the human reference 
genome (GRCh37/hg19) with Burrows-Wheeler Alignment tool 
(BWA; Li H and Durbinv R, 2009)). Peak detection was 
performed with MACS (Zhang et al., 2008).  
2.3 Signal quantification 
In Affymetrix microarrays, the expression signal of each gene 
is quantified summarizing the intensities of all oligonucleotides, 
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i.e. the probes, of a probe set matching a target gene or 
transcript. The signal can be generated using a series of 
statistical or model-based algorithms (e.g., MAS5.0, MBEI, 
RMA, GCRMA) that transform the intensity level into a number 
representing the gene expression level. In this thesis 
expression levels were quantified using directly RMA for data 
produced using the same microarray platform whereas a novel 
procedure was developed for integration of data produced by 
different types of microarray. 
2.3.1 Robust Multichip Average 
Robust Multichip Average (RMA) (Irizarry et al., 2003) 
consists of three steps: background adjustment, quantile 
normalization, and summarization. The RMA method begins 
by computing background-corrected perfect match (PM) 
intensities for each perfect match cell on every array. These 
PM intensities are computed in such a way that all 
background-corrected values must be positive and log-2 
transformed. Then, PM intensities are normalized using the 
quantile normalization method developed by Bolstad et al. 
(Bolstad et al., 2003). Following quantile normalization, an 
additive linear model is fit to the normalized data to obtain an 
expression measure for each probe on each array. Finally, 
signals are summarized using the median polish algorithm. 
The output is a matrix of intensities where each column 
corresponds to a chip and each row is a probe set. 
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2.3.2 Virtual-Chip procedure 
When data have been produced using the same microarray 
platform, the normalization-quantification can be directly 
performed using RMA. If instead different platforms were 
used to obtain the data, as in the case of our meta-database, 
RMA cannot be directly applied but it’s necessary to apply a 
data combination strategy. Data combination integrates 
multiple datasets directly at the level of raw data and 
generates a unique matrix of gene expression signals. The 
direct merging of raw data from different studies is applicable 
only when expression profiles have been obtained using the 
same array technology (e.g. Affymetrix, Agilent, Illumina, etc.) 
and requires an ad-hoc normalization step. We called this 
procedure Virtual-Chip. In Virtual-Chip, raw expression data 
(i.e., CEL files) obtained from at least two different platforms 
are integrated using an approach inspired by the generation 
of custom Chip Definition Files, CDFs (Dai et al., 2005; 
Ferrari et al., 2007). In custom CDFs, probes matching the 
same transcript, but belonging to different probes sets, are 
aggregated into putative custom-probe sets, each one 
including only those probes with a unique and exclusive 
correspondence with a single transcript. Similarly, probes 
matching the same transcript but located at different 
coordinates on different type of arrays may be merged in 
custom-probe sets and positioned in a virtual-grid whose 
geometry can be arbitrarily defined (Figure 2.3).  
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Figure 2.3: Virtual-Chip procedure.	  
As for any other microarray geometry, this virtual grid may be 
used as a reference to create a virtual CDF file containing the 
probes of the Virtual-Chip and their coordinates on the virtual 
platform. The probes included in the virtual CDF are those 
shared among the platforms of interest, with the additional 
condition of generating custom probe set of at least 4 probes. 
The virtual CDF can be derived from any custom CDF, e.g., 
those developed by Dai and publicly accessible at the 
Molecular and Behavioral Neuroscience Institute Microarray 
Lab website. Finally, the virtual CDF can be used as the 
geometry file in RMA as far as the original CEL files are 
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properly re-mapped to match the topology described in the 
virtual CDF. Re-mapped CEL files, called virtual CEL file, are 
homogeneous in terms of platform and gene expression data 
can be generated with a single step of background correction, 
normalization and summarization directly from the 
fluorescence signals of all microarrays composing the meta-
dataset. CEL file re-mapping requires re-defining: 
§ the content of the [HEADER] field, i.e., all physical 
coordinates (total number of cells containing the 
probes, indicated by Cols, Rows, TotalX,and TotalY, 
and localization of the 4 border cells) and the name of 
the platform; 
§ all data contained in the [INTENSITY] field, i.e., 
physical localization (X e Y) and fluorescence intensity 
(MEAN) of any probe. 
 
2.4 Pipeline to reconstruct module networks during 
physiological inflammation 
The transcriptional network of macrophage activation can 
exhibit many distinct steady-states which are associated with 
tissue- and infection-specific macrophage functions. The 
transcriptional response is dynamic and is characterized by 
clusters of gene activated during time and controlled by 
different combinations of transcription factors. Time course 
26 	  
genomic data, coupled with bioinformatics tools for their 
analysis, represents a promising starting point to elucidate the 
transcriptional network of macrophage activation, to identify 
key regulators and their functions during the different stages of 
innate immune response. In this paragraph are described the 
different tools used for the setup of an ad-hoc bioinformatics 
pipeline aimed at reconstructing gene regulatory modules 
during the macrophages activation and polarization. The 
computational process starts with the identification of those 
genes whose expression changes during the time course and 
that, through enrichment analysis, appear to be involved in 
inflammatory processes. These genes can be considered as 
controllers of the process and thus are further used as 
regulators to identify regulatory modules (Figure 2.4). 
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Figure 2.4: bioinformatics pipeline for module network reconstruction. 
2.4.1 Microarray Significant Profiles (maSigPro) 
Time-course microarray experiments are useful approaches 
for exploring biological processes because this type of 
experiments allows scientists to study gene expression 
changes along time and to evaluate trend differences between 
various experimental groups. The large amount of data, the 
presence of several experimental conditions and the dynamic 
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nature of experiments make the analysis very complex. So 
recently, many tools have been developed for time-course 
microarray analysis. In our study genes showing different 
expression profiles along our time-course experiment have 
been identified using the microarray Significant Profiles 
method coded in the maSigPro R package (Conesa et al., 
2006). MaSigPro follows a two steps regression strategy to 
find genes with significant temporal expression changes and 
significant differences between experimental groups. The 
method defines a general regression model for the data where 
the experimental groups are identified by dummy variables. In 
the first step the procedure adjusts this global model by the 
least-squared technique to identify differentially expressed 
genes and selects significant genes applying false discovery 
rate control procedures.  In the second step a variable 
selection strategy is applied to identify statistically significant 
profile differences between experimental groups and to find 
statistically significant different profiles. The coefficients 
obtained in this second regression model will be useful to 
cluster together significant genes with similar expression 
patterns and to visualize the results. The maSigPro package 
contains different types of regression methods and this permits 
to choose an adequate regression model for the data. The 
input is a matrix with gene expression data; the obtained 
output is a matrix with as many rows as significant genes and 
as many columns as parameters in the complete regression 
model. 
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2.4.2 Gene Set Enrichment Analysis (GSEA) 
To understand the biological role of the genes that are 
significantly modulated during the inflammatory response, 
each cluster was subjected to an over-representation analysis 
using the gene set enrichment analysis (GSEA) tool. All genes 
of the microarray are ranked in a list L based on the correlation 
between their expression and a reference gene profile (i.e. 
linearly or exponentially increasing in time). Given an a priori 
defined set of genes S (e.g., genes encoding products in a 
metabolic pathway), the goal of GSEA is to determine whether 
the members of S are randomly distributed throughout L or 
primarily found at the top or bottom rank positions. GSEA is 
characterized by three key elements: 
1. calculation of an Enrichment Score (ES) that reflects 
the degree to which a set S is over-represented at top 
or bottom of the entire ranked list L. The score is 
calculated by walking down the list L, increasing a 
running-sum statistic when a gene in S is encountered 
and decreasing it when genes not in S are 
encountered. The magnitude of the increment can be 
equal at every step (classic statistic) or can depend on 
the correlation of the gene with the reference profile 
(weighted statistic). The enrichment score is the 
maximum deviation from zero encountered in the 
random walk; in the first case it corresponds to a 
standard Kolmogorov–Smirnov statistic (Hollander and 
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Wolfe, 1999); in the second case to a weighted 
Kolmogorov–Smirnov-like statistic; 
2. estimation of significance level of ES (nominal p-value) 
using an empirical gene-set-based permutation test 
procedure. Random gene sets, size matched to the 
actual gene set, are created and their enrichment 
scores calculated. These enrichment scores are used 
to create a null distribution from which the significance 
of the actual enrichment score (for the actual gene set) 
is calculated; 
3. adjustment for multiple hypothesis testing is performed 
by first normalizing the ES for each gene set to account 
for the size of the set, thus yielding a normalized 
enrichment score (NES). Then, the FDR (the estimated 
probability that a set with a given NES represents a 
false positive finding) corresponding to each NES is 
computed to control the proportion of false positives. 
Gene set enrichment analysis is implemented with Molecular 
Signature Database (MSigDb). MSigDb is a publicly accessible 
collection of curated gene sets that is maintained by the GSEA 
team (www.broadinstitute.org/gsea/msigdb/index.jsp; 
Subramanian et al., 2005). The MSigDB gene sets are divided 
into five major collections: 
C1: positional gene sets for each human chromosome and 
each cytogenetic band; 
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C2: curated gene sets from online pathway databases, 
publications in PubMed, any knowledge of domain experts; 
C3: motif gene sets based on conserved cis-regulatory motifs 
from a comparative analysis of the human, mouse, rat and dog 
genomes; 
C4: computational gene sets defined by expression 
neighborhoods centered on 380 cancer-associated genes; 
C5: GO gene sets consist of genes annotated by the same 
GO terms. 
In this thesis, we used a subset of the C2 collection (version 
2.5), i.e. those gene sets derived from BIOCARTA, KEGG, and 
REACTOME pathways database.  
2.4.3 Bayesian networks 
In the last step of our pipeline we used an approach based on 
Bayesian network theory to reconstruct gene regulatory 
network and their associated modules. Bayesian networks 
(BNs), belong to the family of probabilistic graphical models 
(GMs). Each node in the graph represents a random variable, 
while the edges between the nodes represent probabilistic 
dependencies among the corresponding random variables. 
BNs correspond to a GM structure known as a directed acyclic 
graph (DAG). They enable an effective representation and 
computation of the joint probability distribution (JPD) over a set 
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of random variables (Ruggeri et al., 2009). The structure of a 
DAG is constituted by two entities: nodes or vertices and 
directed edges. The nodes represent random variables and 
are usually drawn as circles labeled by the variable names. 
The edges represent direct dependence among the variables 
and are usually drawn by arrows between nodes. In particular, 
an edge from node Xi to node Xj represents a statistical 
dependence between the corresponding variables. Thus, the 
arrow indicates that a value taken by variable Xj depends on 
the value taken by variable Xi, (Xi “influences” Xj ). Node Xi is 
then referred to as a parent of Xj and, similarly Xj is referred to 
as the child of Xi. More formally, a Bayesian network B is an 
annotated acyclic graph that represents a JPD over a set of 
random variables V. The network is defined by a pair B = 〈G, 
Θ〉 where G is the DAG whose nodes X1, X2, …,Xn represent 
random variables, and whose edges represent the direct 
dependencies between these variables. The graph G encodes 
independence assumptions, by which each variable Xi is 
independent of its non descendants given its parents in G. The 
second component Θ denotes the set of parameters of the 
network. This set contains the parameter  for 
each realization  of conditioned on , the set of parents 
of in G. Accordingly, B defines a unique JPD over V, 
namely: 
( )iB iii P πχθ πχ =
iχ iΧ iπ
iΧ
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2.4.4 Genomica: the algorithm  
Bayesian networks are a powerful approach to learn regulatory 
networks but, since in a gene expression dataset the number 
of variables is normally bigger than the number of samples, 
this method tends to overfit the data. To overcome this 
problem Segal and his team implemented in Genomica 
software the module network method, which is a special type 
of Bayesian network algorithm (Segal et al., 2003). In this 
method, each module represents a set of variables that share: 
i) a single variable or a set of variables as their parents and ii) 
local distributions. Compared to standard Bayesian network 
algorithms, this design significantly reduces the number of 
parameters to be learned and consequently leads to more 
accurate inferences. The process of learning module networks 
consists of two steps that are called M-step and E-step: the 
first requires clustering genes into modules and the second 
inferring the regulation program of each module. Segal et al. 
designed an expectation-maximization-based learning 
algorithm that alternates between these two steps. In fact the 
procedure is iterative, which means that involves the 
recurrence of these steps. In each iteration, the method 
searches for a regulation program for each module and then 
reallocates each gene to the module that best describes its 
( ) ( ) ∏∏
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behaviour. At every iteration, the algorithm gives a score to the 
steps, called Bayesian score, and the steps are repeated until 
convergence is reached. The iterative process searches for 
the model with the highest Bayesian score using an 
Expectation Maximization algorithm (Dempster et al., 1977).  
2.4.5 Genomica: the parameters 
The procedure involves loading a matrix containing gene 
expression levels, the choice of analysis parameters and, in 
case, insertion of a list of known and/or putative regulators. 
The algorithm needs to set several parameters: 
• initial clustering method (default is Agglomerative, 
correlation centered); 
• maximum number of modules (based on the number of 
matrix genes); 
• maximum number of iterations; 
• module merge method; 
• scoring method (only Bayesian type is available); 
• lookahead depth; 
• maximum tree depth (based on how big you want 
regulation tree); 
• minimum experiments for contest; 
• candidate regulator genes (it can be load a list of genes or 
can be choose genes from the all in the matrix); 
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• experiment split constraints (experiment sample can be 
divided into different groups based on experiment 
characteristics); 
• known regulator to split on first (it’s possible to choose the 
main regulator of the regulation tree). 
Given these inputs, the algorithm searches simultaneously for 
a partition of genes into modules and for a regulation program 
for each module that explains the expression behavior of 
genes in the module. The regulation program of a module 
specifies the set of regulatory genes that control the module 
and the mRNA expression profile of the genes in the module 
as a function of the expression of the module's regulators. The 
procedure gives as output a list of modules and associated 
regulation programs. This procedure identifies groups of 
coregulated genes, their regulators, the behavior of the module 
as a function of the regulators expression and the conditions 
under which regulation takes place. 
2.5 Pscan: finding over-represented transcription factor 
binding site motifs in sequences 
Once established, through the analysis of the pipeline, that 
genes in the modules are regulated by the same gene network 
and have a common biological function, we want to investigate 
if they are also regulated by the same transcription factors. To 
perform this analysis we used the online method Pscan 
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(http://159.149.160.51/pscan/). Pscan is a software tool that 
scans promoter sequences from co-regulated or co-expressed 
genes, looking for over- or under-represented motifs 
describing the binding specificity of known TFs (Zambelli et al., 
2009), it provides a quick hints on which factors could be 
responsible for the patterns of expression observed, or vice 
versa seem to be avoided. As first step, users have to input a 
set of gene identifiers and to select the organism of 
provenience. Then, users have to specify the promoter region 
to investigate with respect to the transcription start sites 
(TSSs) of the genes and choose whether the analysis has to 
be performed with the TFBSs matrices available in the 
JASPAR or TRANSFAC databases. Given these inputs, for 
each profile, the average matching score obtained from the 
input sequence set can be compared to the mean and the 
standard deviation of the score on the whole genome promoter 
set. The over- (or under-) representation for each profile is 
finally assessed with a z-test, that associates with each profile 
the probability of obtaining the same score on a random 
sequence set (Figure 2.5).  
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Figure 2.5: Pscan outup interface. Motif profiles are ranked according 
to their z-test P-value. 	  
 
2.6 ChIP-seq analysis 
ChIP-sequencing, also known as ChIP-seq, is a method used 
to analyze interactions between DNA and transcription factors 
or other chromatin-associated proteins. ChIP-seq is a two-step 
method that combines chromatin immunoprecipitation (ChIP) 
with massively parallel DNA sequencing (seq) to identify the 
binding sites of DNA-associated proteins. Briefly, proteins 
bound to the DNA are fixed with a cross-linked agent, then 
DNA is fragmented and complexes (protein-DNA) are 
harvested with target antibodies. Finally, cross-links are 
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broken and only DNA fragments from binding sites remain. 
The obtained fragments are sequenced (Figure 2.6). 
Determining how proteins interact with DNA to regulate gene 
expression is essential for fully understanding many biological 
processes and disease states (Park, 2010).  
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Figure 2.6: ChIP-sequencing workflow. 
 
 
For our study, datasets of ChIP-seq were downloaded from 
GEO and were analyzed with methods reported below. We 
protein of interest (TF) 
Antibody binds 
protein of interest 
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performed standard ChIP-seq analysis: peak call, peak 
annotation and motif discovery. 
2.6.1 Model-based Analysis of ChIP-seq (MACS) 
The first step in a ChIP-seq analysis is the peak calling. We 
used MACS (Zhang et al., 2008), that is a ChIP-seq peak-
finding algorithm. MACS performs removal of redundant reads, 
performs read-shifting to account for the offset in forward or 
reverse strand reads and uses control samples and local 
statistics to minimize bias and calculates an empirical FDR 
(Figure 2.7). MACS can be applied to ChIP-seq experiments 
without controls, and to those with controls with improved 
performance. For experiments with a control, MACS linearly 
scales the total control tag count to be the same as the total 
ChIP tag count. MACS allows each genomic position to 
contain no more than one tag and removes all the 
redundancies, moreover tag distribution along the genome 
could be modeled by a Poisson distribution. MACS shifts every 
tag by d/2, it slides 2d windows across the genome to find 
candidate peaks with a significant tag enrichment (Poisson 
distribution). The location with the highest fragment pileup, 
hereafter referred to as the summit, is predicted as the precise 
binding location. If, instead, a ChIP-seq experiment was 
performed with controls, MACS empirically estimates the false 
discovery rate (FDR) for each detected peak using the same 
procedure employed in the previous ChIP-chip peak finders 
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MAT (Johnson et al., 2006) and MA2C (Song et al., 2007). At 
each p-value, MACS uses the same parameters to find ChIP 
peaks over control and control peaks over ChIP (i.e. a sample 
swap). The empirical FDR is defined as Number of control 
peaks / Number of ChIP peaks. 
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Figure 2.7: MACS workflow (Feng et al., 2012). If the control sample 
is missing, then the steps shown in white boxes will be skipped 
(remove redundancy of the control sample, scale two libraries and 
calculate FDR by exchanging treatment and control). 
 
2.6.2 Genomic Regions Enrichment of Annotations Tool 
(GREAT) 
GREAT is a web tool to perform peak annotation and to 
analyze the functional significance of cis-regulatory regions 
identified by localized measurements of DNA binding events 
across an entire genome (McLean et al., 2010). GREAT input 
is a set of genomic regions (in our case a set of transcription 
factor binding site events identified by peak calling analysis). 
As first step GREAT associates proximal and distal input 
genomic regions with their putative target genes, then it uses 
genes annotations from several ontologies to associate 
genomic regions with annotations. Finally, GREAT calculates 
statistical enrichments for associations between genomic 
regions and annotations (Figure 2.8). 
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Figure 2.8: GREAT workflow (McLean et al., 2010) 
2.6.3 MEME-chip 
The MEME-ChIP web service is designed to analyze ChIP-seq 
peaks. MEME-ChIP represents motifs as position-dependent 
letter-probability matrices which describe the probability of 
each possible letter at each position in the pattern (Machanick 
et al., 2011). MEME-ChIP takes as input a group of DNA 
sequences (the training set) and outputs as many motifs as 
requested. MEME-ChIP automatically performs five types of 
analysis on ChIP-seq regions. (i) Ab initio motif discovery 
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identifies novel sequence patterns (motifs) in the ChIP-seq 
regions that may be due to TF binding sites. (ii) Motif 
enrichment analysis looks for enrichment of known TF DNA-
binding motifs in the data. (iii) Motif visualization displays the 
relative locations and binding strengths of TF binding sites in 
the input regions. (iv) Motif binding strength analysis computes 
an estimate of the total DNA-binding affinity of each input 
region for the TF corresponding to each discovered motif. (v) 
Motif identification compares the ab initio motifs to known TF 
DNA-binding motifs. The output of MEME-ChIP is thus a 
multifaceted view of the identities, prevalence, DNA-binding 
patterns and potential interactions of the ChIP-ed TF and its 
regulatory partners. MEME-ChIP employs three motif 
discovery algorithms with complementary characteristics. The 
MEME (Bailey et al., 2006) algorithm uses expectation 
maximization (EM) to discover probabilistic models of DNA-
binding by single TFs or TF complexes. MEME motifs can 
provide accurate thermodynamic models of TF binding. MEME 
is complemented by DREME (Bailey, 2011), which uses a 
simpler, non-probabilistic model (regular expressions) to 
describe the short binding motifs characteristic of single 
eukaryotic TFs. DREME is often able to detect very short 
motifs that are not found by MEME. MEME-ChIP also attempts 
to identify the motifs found by MEME and DREME by 
comparing them to a database of known TF motifs using the 
TOMTOM (Gupta et al., 2007) algorithm. Motif discovery thus 
identifies novel binding motifs and TFs that are regulatory 
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partners of the ChIP-ed TF. MEME-ChIP also implements 
CentriMo or Central Motif Enrichment Analysis that is a tool for 
inferring direct DNA binding from ChIP-seq data. CentriMo is 
based on the observation that the positional distribution of 
binding sites matching the direct-binding motif tends to be 
unimodal, well centered and maximal in the precise center of 
the ChIP-seq peak regions. CentriMo takes a set of sequences 
and plots the occurrence of motifs relative to the ChIP-seq 
peak. Motifs that occur exclusively at the peak provide good 
evidence of direct binding, while motifs that do not occur in a 
consistent position relative to the peak may not bind directly. 
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RESULTS 
3.1 Meta-database of gene expression profiles of immune 
cells 
Twenty-four series comprising 474 gene expression profiles 
were downloaded from GEO, and were organized in a 
proprietary meta-database using AMADMAN. Starting from 
these 474 samples, 303 were selected excluding samples that 
were related to pathological conditions. Samples were 
manually re-annotated and tagged based on the meta-
information provided by GEO and by the original publications. 
Taking advantage of the references, we defined a list of 59 
tags which were then associated to each sample in order to 
describe the most peculiar aspects that could influence the 
gene expression profile.  
 
Tags can be grouped in some major categories, and these are: 
- cellular type (e.g. monocyte, macrophage); 
- purification method (e.g. immunomagnetic or adhesion 
purification); 
- stimuli, either exogenous( LPS) and endogenous( IL4, INFγ); 
- polarization (M1 or M2); 
- quality control of the sample  
 
In particular, we labelled 62 samples as untreated monocytes, 
and 46 and 20 samples as M1 and M2 activated 
monocytes/macrophages, respectively.  
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3.2 Analysis and validation of the inflammation model 
3.2.1 Distinct gene signatures are identified during the 
inflammatory response 
Transcriptomic analysis was performed on the data set of 
physiological inflammation. In particular, 60 gene expression 
profiles of the model were analyzed to identify specific genes 
ofeach stages of immune activation: fresh monocytes (time 0): 
early inflammation (2-4 h), late inflammation (14 h) (both 
corresponding to M1 polarization); early and late resolution (24 
and 48 h) (different stages of M2c polarization). Genes 
showing statistically significant expression changes over time 
were identified using the microarray Significant Profiles 
method coded in the maSigPro R package. Since the time 
course was composed of nine points, we computed a 
regression fit for each gene using a polynomial with a degree 
of 3 (cubic regression model) and selected those regression 
models with an associated corrected p-value ≤0.05. P-values 
have been corrected for multiple comparisons using the false 
discovery rate procedure (FDR), i.e. setting the parameter 
Q=0.05 in the p.vector function. Once determined the 
statistically significant gene models, the regression coefficients 
have been used to identify genes showing statistically 
significant expression changes over time. To do this, a second 
model has been constructed using only significant genes and 
applying a variable selection strategy based on stepwise 
regression. Specifically, we selected the backward stepwise 
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regression and, at each iteration, retained those variables with 
a p-value ≤0.01 (i.e., set the T.fit parameters at step. 
method=backward and alfa=0.01). Finally, we generated the 
list of significant genes setting an additional selection criterion 
based on the R-squared value of the second regression model 
(i.e., set the get.siggenes parameters rsq=0.6 and vars=all). 
Results have been visualized clustering genes into nine 
groups (Figure 3.1) with similar expression profiles (k-means 
clustering method).  
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Figure 3.1: Median gene expression profiles of the 9 clusters 
identified by MaSigPro. Each cluster groups genes with a similar 
trend over time. Solid red lines have been drawn joining the median 
value of gene expression at each time point for each donor (dots). 
In particular, we assembled i) genes of clusters 1 and 2 into 
inflammation functional group ii) genes of clusters 3, 4 and 5 
into anti-inflammation group iii) genes of cluster 6 into 
inflammation driven differentiation group iv) genes of cluster 7 
into positive differentiation and v) genes of clusters 8 and 9 in 
negative differentiation group. The inflammation phase 
corresponds to monocyte-to-M1 macrophages differentiation, 
and is associated with  the modulation of 392 transcripts: 218  
are transiently up-regulated during the first four hours of the 
inflammatory process (Figure 3.1, cluster 1), while 174 remain 
highly expressed during the late phases,  i.e., until 14 h (Figure 
3.1, cluster 2). In both clusters, transcriptional levels decrease 
during the resolution phase (24-48h). Genes included in these 
two groups are the typical effectors of classical activation, such 
as inflammatory cytokines (e.g., PPARG, IL6, TNFA IL1B, 
IL12B), chemokines (e.g., CCL4, CCL5, CCL20), extracellular 
mediators (e.g., PTX3, EDN1, APOL2), and enzymes (e.g., 
PTGS2,  PLA1A). The early anti-inflammatory (Figure 3.1, 
cluster 3) and anti-inflammatory clusters (Figure 3.1, clusters 4 
and 5) contain 850 and 1021 genes, respectively. The anti-
inflammatory phase includes genes involved in metal 
homeostasis, detoxification, modulation of inflammation and 
control of the oxidative stress. The inflammation driven 
differentiation phase consists in 457 genes and which are 
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rapidly up-regulated upon the inflammatory reaction and then 
remain at elevated levels throughout all phases of the reaction 
(Figure 3.1, cluster 6). This behavior arises from the fact that 
this group comprises  genes needed for the inflammatory 
response and also critical for the process of monocyte 
differentiation into deactivating and tissue-repairing 
macrophages. The Positive Differentiation group (Figure 3.1, 
cluster 7) includes 214 genes down-regulated in fresh 
monocytes and during the early inflammation phases, but 
progressively up-regulated during time with a transcriptional 
peak during late resolution. Conversely, the Negative 
Differentiation group (Figure 3.1, clusters 8 and 9) comprises a 
total of 1061 genes highly expressed in fresh monocytes and 
in early inflammation, and reduced during the subsequent 
phases.  
Overall, maSigPro results revealed that a total of 3995 genes 
were differentially expressed during the different phases of the 
inflammatory reaction, and during the concomitant monocyte-
to-macrophage differentiation. The nine clusters generated by 
maSigPro have been merged into five major functional groups 
of genes to reflect the different phases of inflammation (Figure 
3.2).  In particular, genes were organised into five major 
functional groups characterizing the different phases of 
inflammation in this experimental setting: inflammation, early 
anti-inflammation and anti-inflammation, inflammation driven 
differentiation, positive and negative differentiation. 
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Figure 3.2: Differential gene expression during the inflammation. 
Heat-map showing the fold-expression levels of the genes that were 
identified by maSigPro as coherently down-regulated (green) or up-
regulated (red) within the experimental set of 60 samples.  
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3.2.2 Pathway analysis reveals relationship between 
activation and differentiation 
To investigate the biologic role of the genes differentially 
expressed during the development of the inflammatory 
response, each cluster was subjected to an over-
representation analysis for statistical associations between 
expression profiles of distinct groups and other known gene 
signatures characteristic of various pathways or cellular 
processes described in KEGG, BIOCARTA and REACTOME 
databases. Over-representation analysis was performed using 
Gene Set Enrichment Analysis software (GSEA) and the gene 
sets of the Broad Institute Molecular Signatures Database 
(www.broadinstitute.org/gsea/msigdb/index.jsp). GSEA was 
applied on log2 expression data of the entire time course. The 
median expression profile of the 9 groups of genes identified 
by maSigPro was used as continuous phenotype labels and 
Pearson's correlation as the metric to select gene sets with 
expression patterns resembling those encoded in the 
phenotype labels. As gene sets we used KEGG, BIOCARTA, 
and REACTOME lists of the C2 curated gene sets collection. 
We identified a total of 155, 358, 55, 149, and 66 pathways 
most strongly associated with the median expression profile of 
the inflammation, early anti- and anti-inflammation, 
inflammation driven differentiation, positive differentiation and 
negative differentiation clusters, respectively. We found that 
most gene sets associated to the inflammation clusters are 
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classical inflammatory pathways involved in innate immune 
activation (Table 3.1) and, specifically, involved in type I 
inflammatory response carried out by M1 macrophages (such 
as NF-kB, MAPK and JAK-STAT signaling, NOD-like receptor 
and Toll-like receptor signaling, cytokine/chemokine receptor 
interaction, and the IL-1 receptor pathway). The Early Anti-
Inflammation and Anti-Inflammation clusters are enriched in 
pathways associated to metabolism and regulation of gene 
expression (Table 3.1). The modulation of genes involved in 
cellular metabolic activities is characteristic of M2 macrophage 
polarization/differentiation (Martinez et al., 2011), because it 
occurs during the phases of resolution and repair, when major 
rearrangements of cellular functions are required. The 
inflammation driven differentiation group is associated to 
signaling cascades that are in common with both inflammatory 
and anti-inflammatory phases, while pathways enriched in the 
positive differentiation and negative differentiation clusters are 
similar to those found during the anti-inflammatory phase (data 
not shown). Globally, the functional enrichment analysis 
indicates that genes involved in inflammatory response and 
monocytes activation present transcriptional profiles that are 
statistically similar to those of genes involved in the control of 
the different cellular processes (as cell growth/proliferation and 
metabolism) during the monocyte-to-macrophage 
differentiation in vitro. These results establish a transcriptional 
link between monocyte activation and differentiation, 
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inflammation and metabolism on one side and inflammation, 
resolution and cell differentiation on the other.  
 
 
Table 3.1: Most representative gene sets associated with the 
inflammation, early anti-Inflammation and anti-inflammation 
functional groups. 
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3.2.3 The M1 inflammatory signature develops into M2 
during resolution 
To verify if the in vitro model of inflammation can also 
recapitulate the transition from M1 to M2 phenotype 
polarization, we made a comparison between the polarized 
macrophages of the inflammation model and the polarized 
macrophages of the meta-database previously described. To 
this end, samples labeled as unstimulated monocytes, M1 or  
M2 polarized macrophages (Table 3.2) have been extracts 
from meta-data sets of monocytes, macrophages, and 
dendritic cells. In particular we selected and extracted gene 
expression data for 62 fresh monocyte, 46 M1 (treated with 
LPS/TNF-α or IFN-γ) and 20 M2 samples (M2c; treated with 
glucocorticoids, IL-10 or TGF-β).  
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Table 3.2: Complete list of 128 samples labeled as untreated 
monocytes and as M1 and M2 activated monocytes and their 
sources. 
 
Gene expression signals of selected samples of the meta-
database were generated using the Virtual-Chip approach, 
which allows integrating raw expression data (i.e., CEL files) 
obtained from different Affymetrix arrays. Specifically, 
expression values were generated from intensity signals using 
GEO series Platform GEO samples 
Untreated monocytes 
GSE5099 HG-U133A GSM115051; GSM115046; GSM115047; GSM115048; GSM115049; GSM115050 
GSE7807  HG-U133 Plus2.0 GSM189447; GSM189448; GSM189449; GSM189450 
GSE8286  HG-U133A GSM205587; GSM205588; GSM205590; GSM205591; GSM205592; GSM205594 
GSE8658  HG-U133 Plus2.0 
GSM214749; GSM214734; GSM214737; GSM214738; 
GSM214739; GSM214740; GSM214741; GSM214742; 
GSM214743; GSM214744; GSM214745; GSM214746 
GSE9080  HG-U133Av2 GSM230145; GSM230149; GSM230147 
GSE9988  HG-U133 Plus2.0 GSM252476; GSM252478; GSM252479; GSM252480; GSM252481; GSM252484; GSM252485 
GSE11393  HG-U133Av2 GSM287664; GSM287665; GSM287666 
GSE11430  HG-U133 Plus2.0 GSM257664; GSM257666; GSM257668; GSM257670; GSM257672 
GSE11864  HG-U133 Plus2.0 GSM299556; GSM299557; GSM299561; GSM299562 
GSE12108  HG-U133 Plus2.0 GSM305434; GSM305436; GSM305438; GSM305440; GSM305430; GSM305432 
GSE12837  HG-U133A GSM15431; GSM321582; GSM15430 
GSE13762  HG-U133 Plus2.0 GSM346564; GSM346577; GSM346553 
M1 activation 
GSE5099 HG-U133A GSM115055; GSM115057 
GSE9988  HG-U133 Plus2.0 
GSM252423; GSM252424; GSM252425; GSM252427; 
GSM252428; GSM252429; GSM252431; GSM252432; 
GSM252433; GSM252434; GSM252435; GSM252436; 
GSM252437; GSM252438; GSM252439; GSM252440; 
GSM252441; GSM252442; GSM252443; GSM252444; 
GSM252445; GSM252447; GSM252448; GSM252449; 
GSM252450; GSM252451; GSM252453; GSM252454; 
GSM252455; GSM252456; GSM252457; GSM252458; 
GSM252459; GSM252460; GSM252461; GSM252462; 
GSM252463; GSM252464; GSM252430; GSM252426 
GSE14419  HG-U133Av2 GSM360141; GSM360145; GSM360184; GSM360188 
M2 activation 
GSE7568  HG-U133 Plus2.0 
GSM183464; GSM183465; GSM183466; GSM183467; 
GSM183482; GSM183483; GSM183484; GSM183485; 
GSM183486; GSM183487; GSM183217; GSM183305; 
GSM183306; GSM183315; GSM183316; GSM183392; 
GSM183393; GSM183394; GSM183462; GSM183463 !
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the combined HG-U133A/HG-U133Av2/HG-U133 Plus2.0 
virtual CDF file, the custom definition files for human 
GeneChips based on GeneAnnot, and the transformed virtual-
CEL files. Intensity values for a total of 12167 meta-probesets 
were background-adjusted, normalized using quantile 
normalization, and gene expression levels calculated using 
median polish summarization (RMA algorithm). Such matrix of 
gene expression profiles was analyzed with statistical method 
Significance Analysis of Microarray method (SAM), coded in 
the samrR package (http://cran.r-
project.org/web/packages/samr/index.html), to identify 
differentially expressed genes in the comparisons between 
subsets of monocytes tagged as untreated, M1, and M2 (128 
samples). Specifically, in the comparison between untreated 
monocytes and samples labelled as M1 (or as M2), we used 
the two-class procedure, estimated the percentage of false 
positive predictions with 1000 permutations, and selected 
those transcripts whose q-value (i.e., False Discovery Rate, 
FDR) was equal to 0. This selection was further refined setting 
the lower limit for fold change induction (or reduction) to 5 and 
8, when considering the comparison between untreated 
monocytes and samples M1 or untreated monocytes and 
samples M2, respectively. The statistical comparison returned 
that monocyte-to-M1 differentiation is associated with 
modulation of 98 genes, of which 85% are highly expressed in 
M1 and 15% in monocytes (Figure 3.3), while monocyte-to-M2 
differentiation resulted in the modulation of 107 genes, 62% 
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highly expressed in M2 and 38% in monocytes (Figure 3.4). 
Transcripts that are up-regulated in M1 cells vs. monocytes 
included cytokines and chemokines, while those up-regulated 
in M2 cells included enzymes and extracellular mediators. 
 
Figure 3.3: Differentially expressed genes in M1 macrophages vs. 
monocytes. Heat-maps representing the fold-expression levels of 
gene lists identified by SAM as statistically down-regulated (green) or 
up-regulated (red) in M1 samples compared to fresh unstimulated 
monocytes. 
 
  Monocytes    M1 
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Figure 3.4: Differentially expressed genes in M2 macrophages vs. 
monocytes. Heat-maps representing the fold-expression levels of 
gene lists identified by SAM as statistically down-regulated (green) or 
up-regulated (red) in M2 samples compared to fresh unstimulated 
monocytes. 
 
The two signatures of M1 and M2 polarization were used to 
cluster samples of our in vitro model of inflammation. As 
shown in the Figure 3.5, fresh monocytes (recruitment phase) 
showed a gene expression profile fully overlapping with that of 
unstimulated monocytes in the meta-database, then they 
presented a M1-like expression profile during the inflammatory 
phases, to return to a monocyte-like profile in the resolution 
  Monocytes    M2 
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phase. When considering the gene set that discriminates 
monocytes from M2 cells, fresh monocytes (recruitment 
phase) showed the same profile as the untreated monocytes 
of the meta-database, and this profile gradually changed 
during the progression of inflammation, to become similar to 
that of M2 macrophages at the end of resolution phase (Figure 
3.6). When comparing the list of genes differentially expressed 
during the inflammation process (Figure 3.1, Clusters 1 and 2) 
with the list of genes differentially expressed in monocytes vs. 
M1, a large number of genes expressed in M1 cells (34%) 
belongs to the Inflammation group. Conversely, 21% of genes 
expressed in M2 cells belong to the Positive Differentiation 
group (Figure 3.1, cluster 7) and are expressed only during the 
resolution phase. In the monocytes vs. M1 comparison, a large 
part of genes expressed in fresh monocytes belongs to the 
Anti-Inflammation group (26%, Figure x, clusters 4 and 5), 
while in the monocytes vs. M2 comparison 51% of genes 
expressed in monocytes are in the Negative Differentiation 
group (Figure 3.1, clusters 8 and 9). Among genes common to 
both M1 and M2 polarization, several belong to the 
Inflammation Driven Differentiation group (14% and 20%, 
respectively, Figure 3.1, Cluster 6). Table 3.3 shows some 
representative genes identified in these comparisons. 
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Figure 3.5: Fold-expression levels of the 98 monocyte-to-M1 genes 
assessed in the 60 samples of our in vitro model of inflammation. 
 
  Inflammation    Resolution   Recruitment 
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Figure 3.6: Fold-expression levels of the 107 monocyte-to-M2 genes  
assessed in the 60 samples of our in vitro model of inflammation. 
 
  Inflammation    Resolution   Recruitment 
	  	   65	  
 
Table 3.3: Correlation between M1/M2 polarization and functional 
groups.   
 
3.2.4 Validation of gene expression by real-time PCR 
In order to quantitatively validate the microarray results, a total 
of ten genes were examined by real-time PCR, employing the 
same RNA used to hybridize the Affymetrix arrays. A subset of 
ten genes was assessed by qRT-PCR, five transcription 
factors chosen as markers of monocyte differentiation, and five 
inflammation-related factors as markers of monocyte 
activation, selected within each functional group of Figure 3.2. 
The qPCR results confirmed the expression patterns observed 
by microarray analysis (Figure 3.7). Genes belonging to the 
Inflammation group (PPARG, IL6, TNFA) were up-regulated 
Gene Symbol Functional Groups 
Genes uprgulated in M1 polarization 
IL12B, PTX3, CCL4, IL1RN, TNF, IL6, CCL20, IL1A, 
ICAM1, NFKB1, TRAF1, SERPINB9, IL1F9, MAFF Inflammation 
CXCL1, DRAM, TNIP3, CCL2, SLAMF7, CCR7, 
TNFAIP6 
Inflammation Driven Differentiation 
Genes downregulated in M1 polarization 
P2RY5, FGL2, CD1D Anti-Inflammation 
Genes upregulated in M2 polarization 
TREM2, A2M, NUPR1, C1QA, MS4A4A, APOE, APOC1, 
ADORA3 Positive Differentiation 
ADAMDEC1, CD59, TFPI, CCL3 Inflammation Driven Differentiation 
Genes downregulated in M2 polarization 
FCER1A, LGALS2, PF4, CD69, CD93, NR4A2, VCAN, 
CD62L, ICAM3, NLRP3, ERG1 Negative Differentiation 
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during the early phase, while IL7R was over-expressed during 
the late phase of inflammation. CD163 (Early Anti-
Inflammation) was highly up-regulated at the beginning of 
resolution, possibly induced by IL-10, while the transcription 
factor CEBPA (Anti-Inflammation) was overexpressed during 
late resolution, possibly induced by TGF-β. Expression of 
PPARD (Inflammation Driven Differentiation) increased during 
late inflammation and remained elevated, while MAFB and 
MMP9 genes (Positive Differentiation) were up-regulated 
during resolution. Finally, expression of KLF4 (Negative 
Differentiation) was high in fresh monocytes and decreased 
thereafter.   
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Figure 3.7:Fold-expression levels determined by qPCR for the 10 
genes selected. The mean expression values ± SEM from six 
different donors are reported. Statistical significance was calculated 
with ANOVA followed by Fisher’s test for significant differences 
between two consecutive experimental time points. * P < .05 ; ** P < 
.001 ; *** P < .0001 
 
3.3 Reconstruction of module networks during 
physiologic inflammation 
Once established that the in vitro model of inflammation 
accurately recapitulates the development of the human 
inflammatory reaction, we decided to use it to reconstruct gene 
regulatory network. However, extracting new biological insight 
from high-throughput genomic studies of human diseases is a 
challenge, limited by difficulties in recognizing and evaluating 
relevant biological processes among huge quantities of 
expression data. To overcome this problem, it could be very 
helpful to analyze the genes differentially expressed at a 
higher level, the gene sets. We decided to analyse changes in 
monocytes/macrophages gene expression patterns during the 
inflammatory phase in order to better elucidate the 
mechanisms underlying systemic inflammatory responses. To 
this end, we extracted from the original matrix of gene 
expression profile of the in vitro model, a submatrix containing 
only the genes that showed an “inflammation profile” identified 
by maSigPro, as previously described (Figure 3.1, cluster 1 
and 2). GSEA was applied on log2 expression data of the 
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entire time course. The median expression profile of the 
submatrix of the inflammation related genes identified by 
maSigPro was used as continuous phenotype labels, and 
Pearson's correlation as the metric to select gene sets with 
expression patterns resembling those encoded in the 
phenotype labels. The algorithm rank genes based on the 
correlation between their expression and the continuous labels 
using Pearson correlation, then estimates the false discovery 
rate (FDR) to control the probability that each reported result is 
a false positive; this permit to determine the specificity and the 
significance of the analysis. The output of the analysis is a 
ranked list of enriched pathways compared to the genes 
contained in the matrix. A low FDR correspond to a high 
significance of the analysis; in case of time course 
experiments, FDR must be lower than 0.05. Using these 
parameters we obtained 6 gene sets strongly associated with 
the given profile and strongly associated with inflammatory 
reaction. In particular, the analysis of the inflammation cluster 
of maSigPro resulted in the enrichment of the following 
pathways: interleukin-1 receptor (IL-1R), NF-kB activation, 
Cytokines and Inflammatory Response, the nuclear factor-kB 
(NF-kB) pathway (Table 3.4), Cytokine Network, and TNFR2 
Signaling Pathway. 
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Table 3.4: GSEA analysis results obtained using the median 
expression profile from maSigPro inflammation clusters. 
 
Since IL-1R pathway is one of the major pathways that lead 
the inflammation reaction and also one of the most modulated 
pathway in our model (based on previous analysis) we decided 
to focus our attention on the IL-1R pathway. IL-1R family 
detects microbial components and triggers complex signaling 
pathways that result in increased expression of multiple 
inflammatory genes; on the other hand, an aberrant activation 
of IL-1R signaling can promote the onset of inflammatory and 
autoimmune diseases. The signal transduction cascade 
utilized by IL-1 receptor results in NF-kB activation. 
Understanding which are the main protagonists of these 
mechanisms could identify attractive targets for anti-
inflammatory drug discovery, because their inhibition may 
impair a subset of noxious inflammatory signals impinging on 
NF-kB, while sparing its normal physiological activation. In 
particular, we focused on those genes constituting the core 
enrichment of IL-1 receptor pathway in GSEA analysis. The 
Gene Set Name FDR q-val 
BIOCARTA IL-1R PATHWAY 0.046 
BIOCARTA NTHI PATHWAY 0.029 
BIOCARTA INFLAMMATION PATHWAY 0.034 
BIOCARTA NF-Kb PATHWAY 0.044 
BIOCARTA CYTOKYNE PATHWAY 0.049 
BIOCARTA TNFR PATHWAY 0.050 
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core enrichment is the subset of genes of the pathway that 
contributes the most to the enrichment result and contains the 
genes in the experiment data that show the highest correlation 
with the given profile. Through the clustering visualization of 
genes that form the core enrichment pathway of IL1-R, it can 
be seen how the inflammation-related events impact the 
expression changes of the IL1-R pathway (Figure 3.7). 
 
 
 
Figure 3.8: Cluster of genes that form the core enrichment pathway 
of IL-1R. This analysis shows that all the members of the IL-1R 
pathway are highly upregulated during inflammation phase and 
downregulated during resolution and repair phases. 
 
Since our bioinformatics analysis allowed the characterization 
of several members of interleukin-1 family as master 
regulators of the inflammation process, we can consider those 
genes constituting the core enrichment of IL-1R pathway from 
GSEA as regulators of the IL-1R pathway in our model. Once 
we selected potential regulators that mediate the observed 
transcriptional response, the major goal of our work was to 
understand how they interact together and which are the 
transcriptional modules regulated by the gene network of 
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selected regulators. The last step of the pipeline includes the 
use of software GENOMICA. GENOMICA has been applied to 
human in vitro model of physiological inflammation after GSEA 
analysis to look for the transcriptional regulation of genes 
involved in the immune response. Genomica is an analysis 
and visualization tool for genomic data, using this software it is 
possible to reconstruct module networks of sets of genes that 
are coregulated. As input Genomica needs a matrix containing 
gene expression values and a list of putative regulators 
formed, in this case, by the core enrichment genes of GSEA 
analysis. As parameters we specified 0 as lookahead depth 
and 5 as maximum tree depth. The cluster below the 
regulation tree contains regulated genes, i.e, those genes 
whose expression profiles are correlated to the regulators. 
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Figure 3.9: module 1 of IL-1R pathway. Regulation tree of IL-1R 
pathway obtained with Genomica. Red branches show what happens 
when genes are up-regulated instead green branches indicate genes 
down-regulation. A regulation tree or program can represent the 
different modes of regulation described above. Each node in the tree 
consists of a regulatory gene (for example, 'Activator') and a query 
on its qualitative value, in which an red arrow denotes the query "is 
gene up-regulated?" and a green arrow denotes the query "is gene 
down-regulated?". Right branches represent instances for which the 
answer to the query in the node is 'true'; left branches represent 
instances for which the answer is 'false'. The expression of the 
regulatory genes themselves is shown below their respective node. 
 
One of the genes recognized as main regulator by the 
algorithm is interleukin-1A (IL-1A) that is one of the IL-1R 
ligands; the other genes in the tree trace the pathway (Figure 
3.8). The left arm of the tree describes what happens when the 
first regulator is down-regulated and this occurs at time 0 and 
at end of the experiment (24 and 48 hours time points). This is 
confirmed by the fact that a pathway involved in the activation 
of inflammatory response must be turned off at the beginning 
of the experiment and in the final stages, which correspond to 
the resolution of inflammation. The right arm of the tree instead 
illustrates the effects derived from first regulator up-regulation 
that occur in the central phases of the experiment (from 2 to 14 
hours time points) where the inflammatory process takes 
place. The module regulated by this gene network consists of 
183 genes up-regulated during inflammation phase (listed in 
table 6.1).The comparison between Genomica result and the 
validated pathway downloaded from BIOCARTA website 
(www.BIOCARTA.com) denotes the efficacy of the method, 
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since our gene network has almost the same structure of the 
BIOCARTA pathway illustrated in figure 3.9. 
 
 
 
Figure 3.10: validated IL-1R pathway from BIOCARTA website. 
 
Moreover, Genomica tool identified several gene regulatory 
networks showing IL-1R pathway activation in which the signal 
is mediated via classical NF-kB signal members (Figure 3.10 
and Figure 3.11), and in which both genes forming the 
regulation tree and those belonging to the underlying module 
(modulated by regulation tree) are transcriptionally activated 
during the inflammation phase. In particular in figure 3.10 is 
shown a gene regulatory network in which IL-1R, Irak2, IFNB1 
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and MAPK8 are master genes regulating the up-regulation of 
187 target genes contained in that specific module.  
 
 
 
Figure 3.11: module 2 of IL-1R pathway. The second regulation tree 
of IL-1R pathway obtained with Genomica.  
 
 
In figure 3.12 there is another IL-1R network identified by 
GENOMICA, that regulates a module containing 214. This 
module summarizes the IL-1R pathway activation, in which IL-
1R stimulation leads the expression of TNF via NF-kB 
signaling cascade. 
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Figure 3.12: module 3 of IL-1R pathway. The third regulation tree of 
IL-1R pathway obtained with Genomica. 
 
 
3.4 GSEA enrichment 
GSEA has been used to functionally characterize Genomica 
modules. Genes belonging to the modules previously 
described has been analyzed with the “analyze gene sets” tool 
of the MSigDB web pages. Those genes resulted in an 
enrichment of cascades or cellular functions referring to the 
immune system and metabolic process. Tables 3.5, and 3.6 
report the enrichment result using genes from the first and  
from the second Genomica modules previously showed. In 
particular the first and the second modules are significantly 
enriched in pathways related to the inflammatory process while 
the third seems to be made up genes involved in metabolic 
process and regulation of transcription (data not shown).  
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Table 3.5: Enrichment results using genes from the module 1 of IL-
1R reconstructed with Genomica. 
 
 
 
 
Table 3.6: Enrichment results using genes from the module 2 of  IL-
1R modules reconstructed with Genomica. 
 
3.5 Pscan analysis  
Transcription is modulated by the interaction of transcription 
factors with their corresponding binding sites on the DNA 
GENE SET NAME  FDR q-value 
REACTOME_IMMUNE_SYSTEM 4.65E-05 
REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM 2.26E-04 
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION 2.26E-04 
REACTOME_HEMOSTASIS 2.26E-04 
REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS 1.50E-03 
REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES 1.17E-02 
REACTOME_INTERFERON_SIGNALING 2.99E-02 
REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS 3.40E-02 
REACTOME_SIGNALING_BY_ILS 4.97E-02 
GENE SET NAME  FDR q-value 
REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM 5.80E-06 
REACTOME_IMMUNE_SYSTEM 4.22E-05 
REACTOME_SIGNALING_BY_ILS 7.49E-04 
REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX 7.49E-04 
REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER 1.69E-03 
REACTOME_IL1_SIGNALING 1.69E-03 
REACTOME_SIGNALING_BY_NOTCH 4.71E-03 
REACTOME_INTERFERON_ALPHA_BETA_SIGNALING 9.10E-03 
REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION 1.03E-02 
REACTOME_SIGNALING_BY_NOTCH1 1.03E-02 
REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE 1.38E-02 
REACTOME_INTERFERON_SIGNALING 2.10E-02 
REACTOME_INNATE_IMMUNE_SYSTEM 3.82E-02 
REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS 4.23E-02 
GENE SET NAME  FDR q-value 
REACTOME_IMMUNE_SYSTEM 4.65E-05 
REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM 2.26E-04 
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION 2.26E-04 
REACTOME_HEMOSTASIS 2.26E-04 
REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS 1.50E-03 
AN IVIRAL MECHANISM_BY_IFN_STIMULATED_GENES 1 17 2
_INTERFERON_SIGNALING 2.99 -02 
REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS 3.40E-02 
REACTOME_SIGNALING_BY_ILS 4.97E-02 
GENE SET NAME  FDR q-value 
REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM 5.80E-06 
REACTOME_IMMUNE_SYSTEM 4.22E-05 
REACTOME_SIGNALING_BY_ILS 7.49E-04 
REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX 7.49E-04 
REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER 1.69E-03 
REACTOME_IL1_SIGNALING 1.69E-03 
REACTOME_SIGNALING_BY_NOTCH 4.71E-03 
REACTOME_INTERFERON_ALPHA_BETA_SIGNALING 9.10E-03 
REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION 1.03E-02 
REACTOME_SIGNALING_BY_NOTCH1 1.03E-02 
REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE 1.38E-02 
REACTOME_INTERFERON_SIGNALING 2.10E-02 
REACTOME_INNATE_IMMUNE_SYSTEM 3.82E-02 
REACTOME_AMINO_ACID_AND_OLIGOPEPTIDE_SLC_TRANSPORTERS 4.23E-02 
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sequence. To asses which motifs are significantly over-
represented in the promoters of genes comprise in the 
modules, we performed an analysis using Pscan. Pscan is a 
software tool that scans promoter sequences from co-
regulated or co-expressed genes, looking for the most 
represented motifs describing the binding specificity of known 
TFs. We performed the analysis defining the promoter region 
as 450 bp upstream and 50 bp downstream the transcription 
start sites (TSSs) of the genes and using transcription binding 
sites matrices in JASPAR database. As expected, the most 
over-represented TFs in modules obtained with Genomica 
analysis was NF-kB. Surprisingly we found that many modules 
are also enriched in genes that show a binding site motif for 
Sp1 despite the gene regulatory network that governs the 
modules has several genes that belong to NF-kB signal 
transduction pathway as mainly signal transductors. Moreover 
Sp1 doesn’t belong to the core enrichment of the IL-1R 
pathway. The protein encoded by Sp1 gene is a zinc finger 
transcription factor that binds to GC-rich motifs of many 
promoters. The encoded protein is involved in many cellular 
processes, including cell differentiation, cell growth, apoptosis, 
immune responses, response to DNA damage, and chromatin 
remodeling. Our analysis suggests that there could be a 
cooperative action of the two TFs during activation of 
inflammation. Previous studies confirm our hypothesis, data 
from literature have shown that the activation of genes by NF-
κB transcription factors may be modulated by synergistic or 
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antagonistic interactions with other promoter-bound 
transcription factors. For example, Sp1 sites are often found in 
NF-κB-regulated genes, and Sp1 can activate certain 
promoters in synergism with NF-κB through nonoverlapping 
binding sites (Hirano et al., 1998). In particular, we have found 
that in all three modules examined, Sp1 is significantly 
overrepresented, with a p-value equal to 0.00044, 0.00025, 
0.00055 for module 1, 2 and 3 respectively.  
3.6 ChIP-seq analysis 
In order to show that the genes found in Genomica analysis 
are true targets of NF-kB, Sp1, or both, we analyzed some 
ChIP-seq data sets. ChIP-seq is a technique that allows to 
combine chromatin immunoprecipitation (ChIP) with massively 
parallel DNA sequencing to identify the binding sites of DNA-
associated proteins. In particular, we used two ChIP-seq data 
set: one in which immunoprecipitation was performed with 
specific antibodies against Sp1 and one with specific 
antibodies against a subunit of NF-kB (p65), both after 
stimulation with LPS. We retrieved genomic regions with 
significant ChIP-seq peaks and, through an analysis with 
MEME-ChIP web service, we confirmed that the most over-
represented motifs in the peaks, were those associated to the 
immunoprecipitated factors. Therefore, we associated peaks 
with genes using GREAT peaks annotation tool. We identified 
as target genes of Sp1 or NF-kB all these genes that are 
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comprised between -10000 and 2000 bp from peaks identified 
by Homer and annotated with GREAT. To asses if there is a 
significant overlap between genes belonging to genomica 
modules and TFs targets identified with ChIP-seq (Figure 
3.12), we performed an enrichment test using the 
hypergeometric distribution and corrected p-values for FDR 
(BH correction). All three considered modules display a highly 
significant enrichment in both Sp1 and p65 targets (Table 3.9).  
 
Figure 3.13: Venn diagrams show the overlaps between genes 
obtained from ChIP-seq analysis and genes belonging to (A) module 
1, (B) module 2 and (C) module 3. 
80 	  
 
 
Table 3.7: Genes in common between genes obtained from ChIP-
seq analysis and genes belonging to module 1, module 2 and 
module 3 . 
 
 
Table 3.8 Benjamini–Hochberg corrected P-values representing 
enrichment of module genes   
  
3.7 Validation of IL-1B up-regulation during inflammatory 
phase 
In order to validate the enrichment results, one of the most 
important protagonist of IL-1R pathway, i.e. cytokine IL-1β, 
Genes in common between the results of ChIP-seq analysis of NF-kB, 
Sp1and genes in the module 1 
DCP1A, BACH1, CRK, ITGB1, RNF19A, NINJ1, SQSTM1, SLC39A13, TXNL4B, 
G3BP1, PPAP2A, DEGS1, TRIO, KPNA4, IFNGR2, PANK3, RELB, TEX10, 
AZIN1, PIM3, CPD, TCP1, RAB8B 
Genes in common between the results of ChIP-seq analysis of NF-kB, 
Sp1and genes in the module 2 
DGAT2, NR4A3, MTHFD1L, TNFSF14, TNFAIP3, HIVEP1, NFAT5, PTGER2, 
REL, RAPH1, NFKBIZ, OSGIN1, BTG2, SLC7A1, DENND4A, ARRDC4, 
INSIG1, FAM126A, NFKBID, IL23A  
Genes in common between the results of ChIP-seq analysis of NF-kB, 
Sp1and genes in the module 3 
FEM1C, SERPINB8, CTNNB1, ITGB1, HMGA1, EDEM1, STK40, HOMER1, 
SPAG9, MAPK6, SLC35F5, CEBPG, NDRG1, TRIB3, SERTAD1, ZCCHC6, 
HNRNPL, PIM3, VRK2, CRY1, NUMB, CHIC2  
Module N° Sp1 q-val NF-kB q-val 
1  5.03E-09    1.60E-08 
2 3.83E-03 1.76E-07 
3 2.60E-03 7.95E-07 
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was examined by real-time PCR, employing the same RNA 
used to hybridize the Affymetrix arrays, and its protein 
production was assessed by ELISA analysis. As show in figure 
3.13 we obtained in vitro the same results of in silico analysis 
i.e. the exposure to inflammatory stimuli (LPS and TNF-α) 
induced an early (4 h) increase in gene expression of IL-1β, 
while it was down-regulated during the late phase of 
inflammation (at 14 h, after the addiction of IFN-γ in culture). 
The protein production reported as the velocity of production 
(pg or ng/hr/million cells), confirmed the inflammatory role of 
IL-1β highlighting its abundant presence during the full (14 h) 
development of the inflammatory response, with a significant 
decrease in the later phases. 
 
 
Figure 3.14: Gene expression and protein production of IL-1B during 
the different phases of inflammatory reaction. Soluble protein 
recovered in the supernatant is reported in terms of velocity of 
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production, (the amount of protein produced per one million cells per 
hour). Statistical significance was calculated with ANOVA followed by 
Fisher’s test for significant differences between two consecutive 
experimental time points.* P < 0.05 ; ** P < 0.001 ; ***P < 0.0001. 
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DISCUSSION 
The continuing use of high-throughput assays to investigate 
cellular responses to infection is providing a large repository of 
information. Most of these data is organized in public 
databases and their meta-analysis represents an enormous 
opportunity to study the mechanisms of immunological 
processes. However, their meta-analysis is a complex 
challenge for bioinformatics. Collection and analysis of public 
gene expression remains a process which is long and easily 
affected by errors, further complicated by the heterogeneity of 
microarray technologies and the characterization of samples. 
These latter aspects are the most critical problems affecting 
the meta-analysis approaches, in fact different design of 
microarray platforms complicate the integration of already 
incomplete, and often inadequately characterized samples, 
limiting the robustness of the statistical analysis. Many 
software and web applications have been proposed for the 
recovery, the organization and meta-analysis of microarray 
expression data obtained and deposited in public databases. 
However, none of them offers the possibility to download and 
organize locally the raw data and related meta-information, re- 
annotate samples using meta-data, group the samples 
according to the user's choices and integrate and standardize 
data from different platforms. To overcome the problem of 
incomplete and inadequate characterization of the samples, 
we constructed and annotated a meta-database of gene 
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expression profiles of monocytes, macrophages and dendritic 
cells, obtained from public databases in AMADMAN. 
Moreover, to overcome the problem of the integration of 
different platforms we proposed and implemented a process of 
integration and standardization of meta-analysis, called Virtual-
Chip. The innovative aspect of this approach is that the 
integration of different platforms is performed before the 
generation of signal directly at the level of the probes on the 
microarray, in practice we normalize the fluorescence signals 
and quantify the level of expression as if all the different 
samples were obtained with the same type of platform. 
AMADMAN coupled with the Virtual-Chip procedure were 
applied to create, annotate and analyze a gene expression 
meta-database of monocytes, macrophages and dendritic 
cells, derived from 24 different experiments stored in GEO. 
The meta-database was used to validate an owner experiment 
(including 60 samples). Specifically, the experiment is an in 
vitro model of physiological inflammation that consists in a 48 
hour culture of primary human monocytes isolated from 9 
healthy donors. During the culture monocytes are exposed 
sequentially to a series of stimuli that mimic conditions in a 
simplified microenvironment that develops in inflamed tissue. 
The samples were taken at time 0, 4, 14, 24 and 48 hours and 
processed for analysis of transcriptional profiles with 
microarray. Using the expression matrix of the model and the 
tool maSigPro, we found distinct clusters of genes that are 
differentially regulated during the different phases of 
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inflammation. By comparing the genes differentially expressed 
between monocytes vs. M1 and vs. M2, it is evident that 
monocytes in our model show the M1 transcriptome in the 
inflammatory phase and an M2 profile during resolution. Thus, 
that the genes involved in inflammatory activation belong to 
the same biological pathways involved in cellular processes of 
monocyte-to-macrophage differentiation establishes a 
transcriptional connection between monocyte activation and 
differentiation, inflammation and metabolism. Therefore, 
resolution of inflammation is strictly connected to macrophage 
differentiation in the tissue. However, measurement of mRNA 
levels can provide only a partial view of the regulatory state of 
a cell during inflammation. At present, unfortunately, there 
remain major technical difficulties to elevate the analysis from 
gene lists to signaling pathways and transcriptional networks. 
In particular, many tools have been developed for the 
reconstruction of molecular mechanism in cancer (Agnelli et 
al., 2011) while there is a lack of methodologies for unveiling 
these mechanism in inflammatory diseases. With the aim of 
characterizing the functions of specific genes, the relationships 
among these genes, their regulation and coordination during 
inflammatory reaction we setup an ad-hoc pipeline. 
Specifically, in a first step we used several computational 
methods to identify those network components that have a 
critical role in the innate immune system and in a second step 
we adopted concepts from the Bayesian network theory to 
reconstruct gene regulatory network and their associated 
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modules. Using these methods in the appropriate order we 
have been able to identify “master regulator” genes, i.e., genes 
that, although not necessarily associated with any specific 
phenotype, nevertheless play a fundamental role in the web of 
transcriptional interactions. Then we used these genes to 
reconstruct regulatory networks that take places during 
physiological inflammation. This analysis permitted to 
reconstruct transcriptional modules regulating monocytes 
differentiation during physiological inflammation. The designed 
pipeline has allowed to reproduce the pathway of IL-1R and to 
decipher the cascade of genes that derived from this process. 
In particular, on these genes, we performed an enrichment 
analysis through which it was possible to assess that the 
genes of the modules are enriched in inflammation genes and 
genes related with metabolic process. We performed also an 
enrichment analysis to asses which motifs are significantly 
over-represented in the promoters of genes comprised in the 
modules. We found that most of genes show a binding site 
motif for NK-kB, as we expected since the stimulation of IL-1R 
leads to an activation of NF-kB signalling cascade. However, 
also putative Sp1 targets were over-represented in our 
modules. This may suggests that there is a cooperative action 
of the two TFs during activation of inflammation. Data from 
literature (Hirano et al., 1998) have shown that in most 
vertebrates NF-κB factors interact with Sp1. To verify if genes 
in the modules are true targets of NF-kB and Sp1, we 
performed a comparison between data from the physiological 
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inflammation model and data obtained from ChIP-seq analysis. 
This comparison showed that there is an actual contribution to 
the expression of genes in the three modules from the two 
TFs. So, through our pipeline, it is possible to identify genes 
that characterize the various steps of the inflammatory 
process, understand which are the pathway enriched in the 
different steps of inflammation, and, through the extraction of 
the core enrichment of a pathway of interest, understand which 
genes actually govern its activation.  Finally it is possible to 
investigate the genes modulated by the gene network built with 
the core enrichment, to find new targets of a pathway of 
interest or to make new hypotheses about gene interactions.  
CONCLUSIONS 
Here, we report the setup of a physiological inflammation 
model, a bioinformatics approach to analyze it and an ad-hoc 
pipeline to reconstruct module networks from these data.  
We demonstrated that i) the in vitro system based on primary 
human cells can allow us to describe the kinetic development 
of cell reactivity and its modulation during the entire course of 
the inflammatory response in a robust and reliable fashion, ii) 
there is a transcriptional link between monocyte activation and 
differentiation, inflammation and metabolism on one side and 
inflammation, resolution and cell differentiation on the other, iii) 
monocytes can shift from M1 to M2 polarization upon 
microenvironmental changes.  
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The fact that the same monocyte population goes through all 
the phases of the inflammatory process by adapting its 
phenotype and function to the evolution of microenvironmental 
conditions was already suggested by studies in mouse 
models, but never previously shown for human cells.  
Finally, in order to reconstruct gene regulatory modules based 
on the transcriptional data of the inflammation model, I 
developed ad-hoc bioinformatics pipeline. This approach 
allowed the characterization of several member of the 
interleukin-1 receptor pathway as master regulators of specific 
regulatory modules linked to the inflammation process and, 
through scanning analysis of transcription factor (TF) binding 
site motifs, we identified genes putatively regulated by the 
cooperation of the transcription factors nuclear factor kappa-
light-chain-enhancer of activated B cells (NF-kB) and 
specificity protein 1 (Sp1). Finally,I was able to validate the 
results using a ChIP-seq data sets.  
Overall I demonstrate that it is possible to investigate the 
genes modulated by the gene network built with the core 
enrichment, to find new targets in a complex biological system 
such as the immune system and to make new hypotheses 
about gene interactions  
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